Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
Abstract Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complete response (pCR) and long-term survival, on the basis of reconstructed...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4954ec4b091b4a899a745afe74bf1b92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4954ec4b091b4a899a745afe74bf1b92 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4954ec4b091b4a899a745afe74bf1b922021-11-14T12:29:54ZSurvival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data10.1186/s12885-021-08922-11471-2407https://doaj.org/article/4954ec4b091b4a899a745afe74bf1b922021-11-01T00:00:00Zhttps://doi.org/10.1186/s12885-021-08922-1https://doaj.org/toc/1471-2407Abstract Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complete response (pCR) and long-term survival, on the basis of reconstructed individual patient data (IPD). Methods The PubMed, Embase, Ovid and Cochrane CENTRAL databases were searched. The primary endpoint was to evaluate the survival landscape of different TRGs after neoadjuvant therapy and the secondary endpoint was to evaluate the associations between pCR and survival. IPD were reconstructed with Kaplan–Meier curves. Results The 10-year overall survival (OS) and 5-year disease-free survival (DFS) were clearly higher in the pCR group than in the non-pCR (npCR) group (80.5% vs. 48.3, 90.1% vs. 69.8%). Furthermore, the OS and DFS increased with improvement in tumor regression after neoadjuvant therapy. According to the IPD, the pCR group had longer OS (HR = 0.240, 95% CI = 0.177–0.325, p < 0.001) and DFS (HR = 0.274, 95% CI = 0.205–0.367, p < 0.001) than the npCR group. Better tumor regression was associated with better survival outcomes (p < 0.005). Direct calculation of published HR values yielded similar results. Conclusions Our results indicate a positive relationship between better tumor regressions and improved survival benefits among the npCR group and patients with rectal cancer achieving pCR had much longer OS and DFS than patients achieving npCR, presenting a survival landscape of different TRGs and pCR in rectal cancer after neoadjuvant therapy.Jia-yi LiXuan-zhang HuangPeng GaoYong-xi SongXiao-wan ChenXing-er LvYv FuQiong XiaoShi-yv YeZhen-ning WangBMCarticleRectal cancerNeoadjuvant therapyPathological complete responseTumor regression gradeSurvivalNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Rectal cancer Neoadjuvant therapy Pathological complete response Tumor regression grade Survival Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Rectal cancer Neoadjuvant therapy Pathological complete response Tumor regression grade Survival Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Jia-yi Li Xuan-zhang Huang Peng Gao Yong-xi Song Xiao-wan Chen Xing-er Lv Yv Fu Qiong Xiao Shi-yv Ye Zhen-ning Wang Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
description |
Abstract Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complete response (pCR) and long-term survival, on the basis of reconstructed individual patient data (IPD). Methods The PubMed, Embase, Ovid and Cochrane CENTRAL databases were searched. The primary endpoint was to evaluate the survival landscape of different TRGs after neoadjuvant therapy and the secondary endpoint was to evaluate the associations between pCR and survival. IPD were reconstructed with Kaplan–Meier curves. Results The 10-year overall survival (OS) and 5-year disease-free survival (DFS) were clearly higher in the pCR group than in the non-pCR (npCR) group (80.5% vs. 48.3, 90.1% vs. 69.8%). Furthermore, the OS and DFS increased with improvement in tumor regression after neoadjuvant therapy. According to the IPD, the pCR group had longer OS (HR = 0.240, 95% CI = 0.177–0.325, p < 0.001) and DFS (HR = 0.274, 95% CI = 0.205–0.367, p < 0.001) than the npCR group. Better tumor regression was associated with better survival outcomes (p < 0.005). Direct calculation of published HR values yielded similar results. Conclusions Our results indicate a positive relationship between better tumor regressions and improved survival benefits among the npCR group and patients with rectal cancer achieving pCR had much longer OS and DFS than patients achieving npCR, presenting a survival landscape of different TRGs and pCR in rectal cancer after neoadjuvant therapy. |
format |
article |
author |
Jia-yi Li Xuan-zhang Huang Peng Gao Yong-xi Song Xiao-wan Chen Xing-er Lv Yv Fu Qiong Xiao Shi-yv Ye Zhen-ning Wang |
author_facet |
Jia-yi Li Xuan-zhang Huang Peng Gao Yong-xi Song Xiao-wan Chen Xing-er Lv Yv Fu Qiong Xiao Shi-yv Ye Zhen-ning Wang |
author_sort |
Jia-yi Li |
title |
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
title_short |
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
title_full |
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
title_fullStr |
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
title_full_unstemmed |
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
title_sort |
survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/4954ec4b091b4a899a745afe74bf1b92 |
work_keys_str_mv |
AT jiayili survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT xuanzhanghuang survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT penggao survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT yongxisong survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT xiaowanchen survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT xingerlv survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT yvfu survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT qiongxiao survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT shiyvye survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata AT zhenningwang survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata |
_version_ |
1718429163885428736 |